A Breast Cancer Specialist is a healthcare professional who dedicates their practice to the care and treatment of breast cancer patients. These specialists typically include oncologists, surgeons, radiologists, and other experts trained in the complexities of breast cancer. Their role is crucial in accurately diagnosing the disease through tools like mammograms, ultrasounds, and biopsies, and then creating individualized treatment plans tailored to the patient’s specific type and stage of cancer. Treatments recommended by breast cancer specialists may involve surgery, chemotherapy, radiation, hormonal therapy, or targeted therapy, depending on the unique characteristics of the tumor. Their focused expertise ensures that patients receive the most effective, evidence-based care available, improving both survival rates and quality of life.
In addition to treatment, breast cancer specialists emphasize prevention, early detection, and patient education. They stay updated with the latest research developments and clinical trials to offer cutting-edge therapies. These specialists also provide compassionate support, helping patients and their families cope with the emotional challenges of a cancer diagnosis. By working closely with multidisciplinary teams, breast cancer specialists coordinate comprehensive care plans that address not only the physical aspects of cancer but also the psychological and social needs of their patients. Their specialized knowledge and dedication make them key figures in advancing breast cancer treatment and patient well-being.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China